You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antiviral

Showing 1 - 25 of 3,604
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

Enrolling by invitation
  • Multiple Sclerosis
  • Truvada (tenofovir/emtricitabine)
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 14, 2023

Passage of Antiviral Antibodies From Mother to Child

Not yet recruiting
  • Pregnant Woman
  • Adult Patient
  • Blood sample and data collection
  • (no location specified)
Apr 24, 2023

Clinical Trials of Investigational or Licensed Vaccines or

Recruiting
  • Vaccines
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Respiratory Syncytial Virus (RSV) Trial in London (RV299, Placebo)

    Completed
    • Respiratory Syncytial Virus (RSV)
    • London, United Kingdom
      Pfizer
    Oct 5, 2023

    Chronic Hepatitis B Trial in Seoul (Standard of care)

    Active, not recruiting
    • Chronic Hepatitis B
    • Standard of care
    • Seoul, Korea, Republic of
    • +3 more
    Mar 29, 2023

    Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

    Recruiting
    • Chronic HBV Infection
    • Peginterferon alfa-2b combined and ETV
    • Shenzhen, China
      Shenzhen Third People Hospital
    Mar 19, 2023

    Real World COVID-19 Antiviral Effectiveness Research

    Not yet recruiting
    • COVID-19
    • Oral Antiviral
    • (no location specified)
    Dec 4, 2022

    Periodontitis Chronic Generalized Severe Trial in Nice, Marseille, Rennes (Antiviral treatment with conventional non-surgical

    Not yet recruiting
    • Periodontitis Chronic Generalized Severe
    • Antiviral treatment with conventional non-surgical treatment
    • Placebo with conventional non-surgical treatment
    • Nice, Alpes Maritimes, France
    • +2 more
    Jun 5, 2023

    CMV Antiviral T-cell Immunity Over Next Six Months Initiation of

    Not yet recruiting
    • Kidney Transplant Infection
    • (no location specified)
    Jan 23, 2023

    Nirmatrelvir-ritonavir in Hospitalized Patients

    Recruiting
    • Hospitalized Patients
    • Hangzhou, Zhejiang, China
      Changcheng Shi
    Feb 26, 2023

    Metabolic Syndrome on Antiviral Response in People With Chronic

    Not yet recruiting
    • Chronic Hepatitis b
      • (no location specified)
      Jan 21, 2023

      Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

      Not yet recruiting
      • Hepatitis B, Chronic
      • Exposure factors
      • (no location specified)
      Sep 10, 2023

      Influenza, Influenza, Human Trial in Bangkok (Drug: Oseltamivir, Drug: Favipiravir, Drug: Zanamivir)

      Not yet recruiting
      • Influenza
      • Influenza, Human
      • Drug: Oseltamivir
      • +6 more
      • Bangkok, Thailand
        Faculty of Tropical Medicine, Mahidol University
      Jan 30, 2023

      Nutrition, Healthy Trial (fish oil)

      Not yet recruiting
      • Nutrition, Healthy
      • fish oil
      • (no location specified)
      Aug 12, 2022

      Gastric Cancer Trial in Seoul (Antiviral treatment in combination with low-dose gemcitabine)

      Not yet recruiting
      • Gastric Cancer
      • Antiviral treatment in combination with low-dose gemcitabine
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 21, 2022

      COVID-19 Infection and Its Clinical Prognosis in Chronic

      Recruiting
      • Chronic Hepatitis B
      • COVID-19 Infection
      • Beijing, Beijing, China
        Department of Hepatology Division 2, Beijing Ditan Hospital
      Mar 28, 2023

      Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney

      Recruiting
      • Diabetes Mellitus
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 27, 2023

      Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

      Active, not recruiting
      • Chronic Hepatitis B
      • Guangzhou, Guangdong, China
        Nanfang Hospital, Southern Medical University
      Apr 20, 2023

      COVID-19, Immunodeficiency Trial (Paxlovid 5 days, Paxlovid 10 days, Tixagevimab and Cilgavimab)

      Not yet recruiting
      • COVID-19
      • Immunodeficiency
      • Paxlovid 5 days
      • +2 more
      • (no location specified)
      Oct 18, 2022

      Antiviral Therapy for Patients With Liver Cancer After Surgery

      Recruiting
      • Hepatocellular Carcinoma
        • Changsha, Hunan, China
          Xiangya Hospital of Central South University
        Jul 19, 2022

        Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)

        Active, not recruiting
        • Covid19
        • Omalizumab
        • Placebo
        • Niagara, Ontario, Canada
        • +2 more
        Nov 14, 2022

        Early Antiviral Responses to Rhinovirus Infection in Asthma

        Not yet recruiting
        • Asthma
        • Rhinovirus infection
        • (no location specified)
        Mar 29, 2022

        Antiviral Drugs on the Treatment of SARS-CoV-2

        Recruiting
        • Complication of Medical Care
        • Pneumonia, Viral
        • Nur-Sultan, Kazakhstan
        • +1 more
        Jul 19, 2022

        Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

        Active, not recruiting
        • Chronic Hepatitis B and Hepatitis D Co-infection
        • HH-003 20mg/kg
        • HH-003 3mg/kg
        • Changchun, Jilin, China
          First Hospital of Jilin University
        Dec 30, 2022

        Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

        Not yet recruiting
        • Liver Cancer
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 9, 2023